History of gene therapy |
| |
Authors: | Thomas Wirth,Nigel Parker,Seppo Ylä -Herttuala |
| |
Affiliation: | 1. A.I. Virtanen Institute, Biotechnology and Molecular Medicine Unit, Univ. of Eastern Finland, Kuopio, Finland;2. FKD Therapies Oy, Kuopio, Finland;3. Research Department, Kuopio University Hospital, Kuopio, Finland;4. Gene Therapy Unit, Kuopio University Hospital, Kuopio, Finland |
| |
Abstract: | Two decades after the initial gene therapy trials and more than 1700 approved clinical trials worldwide we not only have gained much new information and knowledge regarding gene therapy in general, but also learned to understand the concern that has persisted in society. Despite the setbacks gene therapy has faced, success stories have increasingly emerged. Examples for these are the positive recommendation for a gene therapy product (Glybera) by the EMA for approval in the European Union and the positive trials for the treatment of ADA deficiency, SCID-X1 and adrenoleukodystrophy. Nevertheless, our knowledge continues to grow and during the course of time more safety data has become available that helps us to develop better gene therapy approaches. Also, with the increased understanding of molecular medicine, we have been able to develop more specific and efficient gene transfer vectors which are now producing clinical results. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|